Methoxisopropamine
(Redirected from MXiPr)
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine) is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It is the N-isopropyl homologue to methoxetamine. Since it hasn't been extensively studied, the pharmacological effects are unclear, but its effects are reportedly similar to methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]
See also
[edit]References
[edit]- ↑ "Analytical Report for MXiPr" (PDF). National Forensic Laboratory, Police, Ministry of the Interior. Republic of Slovenia. Archived from the original on 2022-01-15. Retrieved 2021-06-09.
(2‐(3‐methoxyphenyl)‐2‐[(propan‐2‐yl)amino]cyclohexan‐1‐one C16H23NO2)
{{cite web}}: CS1 maint: bot: original URL status unknown (link) - ↑ "Amendment of Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances". Minister for Human Capacities. Government of Hungary. 2021/225/HU. Archived from the original on 9 June 2021.
 | This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information. |